Lv5
908 积分 2025-01-07 加入
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
4天前
已完结
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
8天前
已完结
Reappraisal of GIP Pharmacology for Metabolic Diseases
10天前
已完结
Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet–Fed Mice
11天前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
12天前
已完结
Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles
25天前
已完结
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
2个月前
已完结
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
2个月前
已完结
FGF21 Analogues in Patients With Metabolic Diseases: Systematic Review and Meta‐Analysis of Randomised Controlled Trials
2个月前
已完结
Current status and future perspectives of FGF21 analogues in clinical trials
2个月前
已完结
皖公网安备34019202002308